Conclusions and future directions The unexpectedly broad benefits of GLP-1 medicines now extend to reduction in rates of heart failure, stroke, myocardial infarction, diabetic kidney disease, metabolic liver disease, osteoarthritis peripheral vascular disease, and obstructive sleep apnea (Table 1
You should be comfortable with self-administered injections, since there is no in-person training
So while appetite is lower, the medication itself doesnt teach someone how to structure their meals, prioritize protein or fuel their training, and thats where some of the more interesting patterns start to show up
The service operates on a month-to-month subscription model with no long-term contracts, though as we will see from customer reviews, the cancellation process has generated significant complaints
From 2018 to 2021, Biktarvy's sales were $1.18 billion, $4.74 billion, $7.26 billion, and $8.62 billion, respectively
Mounjaro is designed specifically for type 2 diabetes, while Zepbound is intended for chronic weight management